Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Naive and Treatment-Experienced Patients in Canada.
about
Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patientsCost-effectiveness of dolutegravir/abacavir/lamivudine in HIV-1 treatment-Naive (TN) patients in France.The cost-effectiveness and budgetary impact of a dolutegravir-based regimen as first-line treatment of HIV infection in India.
P2860
Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Naive and Treatment-Experienced Patients in Canada.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Cost-Effectiveness of Dolutegr ...... xperienced Patients in Canada.
@ast
Cost-Effectiveness of Dolutegr ...... xperienced Patients in Canada.
@en
type
label
Cost-Effectiveness of Dolutegr ...... xperienced Patients in Canada.
@ast
Cost-Effectiveness of Dolutegr ...... xperienced Patients in Canada.
@en
prefLabel
Cost-Effectiveness of Dolutegr ...... xperienced Patients in Canada.
@ast
Cost-Effectiveness of Dolutegr ...... xperienced Patients in Canada.
@en
P2093
P2860
P1476
Cost-Effectiveness of Dolutegr ...... xperienced Patients in Canada.
@en
P2093
Angela Rocchi
Delphine Anger
Kim Gilchrist
Monique Martin
Neerav Monga
Nicolas Despiégel
Rodrigo Refoios Camejo
Sonia Pulgar
P2860
P2888
P304
P356
10.1007/S40121-015-0071-0
P577
2015-06-23T00:00:00Z